Table 2.
Institution | Gene(s) tested | Platform | CYP2C19 Alleles reported |
---|---|---|---|
University of Alabama at Birmingham | CYP2C19 only | Spartan RX, Spartan Biosciences (Ottawa, ON) | *2, *3, *17 |
University of Pennsylvania | CYP2C19 only | Spartan RX, Spartan Biosciences (Ottawa, ON) | *2, *3, *17 |
University of Florida Health, Jacksonville | CYP2C19 only | Spartan RX, Spartan Biosciences (Ottawa, ON) | *2, *3, *17 |
University of Illinois at Chicago | CYP2C19 only | eSensor XT-8, GenMark Diagnostics (Carlsbad, CA) | *2, *3, *4,*5, *6, *8,, *9, *10, *13,*17 |
University of Florida Health, Shands Hospital, Gainesville | CYP2C19 only* | eSensor XT-8, GenMark Diagnostics (Carlsbad, CA) | *2, *3, *4,*5, *6, *8,*9, *10, *13,*17 |
University of Pittsburgh, UPMC Presbyterian Hospital | CYP2C19 only | eSensor XT-8, GenMark Diagnostics (Carlsbad, CA) | *2, *3, *4,*5, *6, *7,*8, *9, *10,*17 |
University of North Carolina at Chapel Hill | CYP2C19 only | Custom Taqman® assay, ThermoFisher (Waltham, MA) | *2, *3, *17 |
University of Maryland, Baltimore | CYP2C19 only | Custom Taqman® assay, ThermoFisher (Waltham, MA) | *2, *3, *4,*6, *8, *17 |
Sanford Health | CYP2C19 only | BeadXpress ADME Panel, Illumina (San Diego, CA) | *2, *3, *4,*5, *6, *8,*12, *17 |
Indiana University | Panel | Custom Taqman® assay, ThermoFisher (Waltham, MA) | *2, *3, *4,*4B, *6, *8,*10, *17 |
Icahn School of Medicine at Mount Sinai and the Mount Sinai Hospital | Panel | MassARRAY, Agena Biosciences (San Diego, CA) | *2, *3, *4,*5, *6, *7,*8, *17 |
Vanderbilt University | Panel | Custom QuantStudio® assay, ThermoFisher (Waltham, MA) | *2, *3, *4,*5, *6, *7,*8, *17 |
Initially launched with multi-gene panel based testing, but changed to CYP2C19 testing only after the first year